Acquiring Company
Edwards Lifesciences
Acquired Company
Innovalve
Irvine
IsraelManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMedical DeviceBiotechnologyHealth CareMedicalMedical DeviceDescription
Edwards Lifesciences has acquired Innovalve for approximately $300 million in cash. This acquisition follows a previous investment made by Edwards in Innovalve in 2017. The acquired technology aims to revolutionize mitral valve replacement procedures without open-heart surgery. Innovalve's system has shown promising results in initial human trials.
Fundz sees it the moment Edwards Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Innovalve?
Innovalve was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on September 9, 2026. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.
When did Edwards Lifesciences acquire Innovalve?
Edwards Lifesciences's acquisition of Innovalve was reported on September 9, 2026. Edwards Lifesciences has acquired Innovalve for approximately $300 million in cash. This acquisition follows a previous investment made by Edwards in Innovalve in 2017. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Innovalve do?
Innovalve is a medical technology company developing a catheter-based system for mitral valve replacement without the need for open-heart surgery. It is privately held, operating in Biotechnology, and is based in Israel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.